Vaxart, Inc. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Vaxart, Inc. (VXRT) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $1.05 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2012-11-08
- Vaxart, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2012-09-30 was $1.56M.
- Vaxart, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2012-06-30 was $419.00K, a 69.64% decline year-over-year.
- Vaxart, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2012-03-31 was -$924.00K.
- Vaxart, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2011-12-31 was -$3.48M, a 562.55% decline year-over-year.
- Vaxart, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2011 was -$5.86M, a 443.58% decline from fiscal 2010.
- Vaxart, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2010 was $1.71M, a 25.81% decline from fiscal 2009.
- Vaxart, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2009 was $2.30M.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2012-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $1.98M derived: sum of 2 quarters · filed 2012-11-08 | $1.05M 10-Q · filed 2012-11-08 | -$2.43M derived: sum of 4 quarters · filed 2012-11-08 |
| 2012-06-30 | $419.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$505.00K 10-Q · filed 2012-08-09 | -$3.99M derived: sum of 3 quarters · filed 2012-08-09 | -$5.24M derived: sum of 4 quarters · filed 2012-08-09 |
| 2012-03-31 | -$924.00K 10-Q · filed 2012-05-10 | -$4.41M derived: sum of 2 quarters · filed 2012-05-10 | -$5.66M derived: sum of 3 quarters · filed 2012-05-10 | -$4.28M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-12-31 | -$3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | -$4.74M derived: sum of 2 quarters · filed 2012-03-14 | -$3.36M derived: sum of 3 quarters · filed 2012-08-09 | -$5.86M 10-K · filed 2012-03-14 |
| 2011-09-24 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $124.00K derived: sum of 2 quarters · filed 2012-08-09 | -$2.38M 10-Q · filed 2012-11-08 | -$1.62M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-06-25 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$1.12M 10-Q · filed 2012-08-09 | -$366.00K derived: sum of 3 quarters · filed 2012-08-09 | -$923.00K derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-03-26 | -$2.50M 10-Q · filed 2012-05-10 | -$1.75M derived: sum of 2 quarters · filed 2012-05-10 | -$2.30M derived: sum of 3 quarters · filed 2012-05-10 | |
| 2010-12-25 | $753.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $196.00K derived: sum of 2 quarters · filed 2012-03-14 | $1.71M 10-K · filed 2012-03-14 | |
| 2010-09-25 | -$557.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $952.00K 10-Q · filed 2011-11-02 | ||
| 2010-06-26 | $1.51M 10-Q · filed 2011-08-03 | |||
| 2009-12-26 | $2.30M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |